Specialty: Musculoskeletal Disorders, Primary sub-specialty: Non-pharmacological Interventions
Conditions
Interventions
128 patients were recruited to the study and randomised into two arms. Randomization was carried out using dedicated computer software (StratOs vs 1.34, Orthopaedic Institute Ltd, Oswestry, UK) and st
Sponsors
The Orthopaedic Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A patient is eligible for the trial if the patient: 1. Is aged 18+ years 2. Has symptoms consistent with GTPS for at least 6 months 3. Failed conservative management in any other care setting 4. Patient is willing and able to provide written informed consent
Exclusion criteria
Exclusion criteria: A patient is ineligible for the trial if the patient: 1. Has hip joint osteoarthritis requiring treatment on a plain radiograph 2. Had surgical treatment specifically targeted at GTPS within last 6 months e.g. bursectomy/ITB lengthening 3. Has ipsilateral Total Hip Replacement. (patient will not be able to undergo corticosteroid injection in clinic setting) 4. Has contraindictions to ESWT treatment; pregnancy, anticoagulant therapy, advanced peripheral neuropathy, local infection, malignancy, unresolved fractures. 5. Has a previous history of complications with ESWT 6. Has a recent history of acute hip trauma 7. Has a recent history of acute sciatica 8. Is not able to attend or comply with treatment or follow-up scheduling 9. Participates in any other clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain measured using the visual analogue pain score (VAS) at baseline, 3 and 12 months post intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Function assessed using the Harris Hip Score (HHS) and Trendelenburg test at baseline, 3 and 12 months post intervention. 2. Quality of life assessed using the SF-36 at baseline, 3 and 12 months post intervention. 3. Symptom improvement assessed using a Likert scale at 3 and 12 months. 4. Completion of physiotherapy or any problems with any treatments received, assessed using a patient diary kept for 1 year and returned at final follow-up | — |
Countries
England, United Kingdom
Outcome results
None listed